Aurobindo Pharma has informed that a meeting of the Board of Directors of the Company will be held on February 06, 2014, to consider the Un-Audited Financial Results of the Company for the quarter ended December 31, 2013 (Q3).
The above information is a part of company’s filings submitted to BSE.